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Whole MCF-7 human breast-cancer cells were irradiated at -78°C in a calibrated Gammacel ‘%o irradiator. Freezing or storing conditions induce 
neither an alteration of the viability of sells nor a change in estradiol binding activity. Hexosaminidase was used as internal marker, and we mea- 
sured the radiation inactivation size (RIS) of the estrogen receptor in whole cells. After various cell treatments, the esteadiol binding unit always 
presents a molecular mass of 25 kDa. This value, which corresponds to the size of the defined hormone binding domain of the estrogen receptor, 
suggests that the energy delivered to the protein by the radiation is efficient to inactivate estradiol binding only when the hit occurs directly in 
the smaller hormone binding domein. 
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1. INTRODUCTION 
Gene regulation by steroid hormones such as 
estradiol, is a traditional field of research in bio- 
chemical endocrinology. Characterization, purification 
and cloning of receptor genes have been achieved in the 
last 10 years. The human breast cancer cell line MCF-7, 
which possesses the estrogen receptor, is proving to be 
an excellent model for the study of estrogen action. 
Estradiol is able to stimulate cell proliferation otherwise 
specificaly inhibited by the antiestrogen tamoxifen [ 11. 
However, in certain condition: we have reported that 
estradiol remains ineffective for growth stimulation [2]. 
In this work our focus has been to study the molecular 
size of the estradiol binding polypeptide structure in 
whole cells. Previous results obtained by radiation 
fragmentation have shown that the estrogen receptor 
covalently bound with the antiestrogen tamoxifen 
aziridine is part of a protein complex of about 265 kDa 
when cells are at subconfluency or of a 360 kDa species 
in superconfluent cells [3]. It is reported here that in 
whole cells the radiation inactivation size (RIS) of 
estradiol binding is 25 kDa in all the conditions used: 
cells were untreated or submitted to 10 -’ M estradiol or 
lo-’ M tamoxifen, moreover, unlike the target size [3] 
this value is independent of the MCF-7 cellular density. 
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2. MATERIAL5 AND METHODS 
The MCF-7 human breast-cancer cell lint has been adapted to grow 
in serum-free medium and in absence of phenol red as described 
previously [4]. Cells were treated 3 days before scrapping and collec- 
tion; they were frozen at - 17O”C, stored in conditions which do not 
decrease their viability and irradiated at - 78°C. The irradiation pro- 
cedure was conducted on frozen samples (IO’ cells) in a Gammacell 
model 220 instrument (Atomic Energy of Canada, Ottawa, Canada) 
at a dose rate of about 2 Mrad/hour in a special tube rack allowing 
isodose exposure of 2 sets of samples [S]. The data were analyzed with 
the single hit model of radiation inactivation [6] and apparent 
molecuiar weights were caiculated using the empirical formula: log M, 
= 5.89 - log DJ,.~ - 0.0028t. 
Where Du., is the radiation dose (in Mrad) necessary to inactivate 
the estradiol binding or the hexosaminidase activity to 37% of its in- 
itial value, at t, the irradiating temperature in “C [7]. After irradia- 
tion, cells were quickly thawed at 37”C, put on ice, washed with saline 
phosphate buffer and pelleted at 800 x g. [‘H]Estradiol binding assay 
was performed using the ligand exchange procedure described by 
Anderson et al. [8]. Hexosaminidase assay was realized on 20 ~1 
samples of total homogenate as previously described [I)]. 
3. RESULTS AND DISCUSSION 
The inactivation of estradiol binding and hex- 
osaminidase activity occurs as a simple exponential 
function of the radiation dose (Fig. 1) in agreement with 
the target theory of Lea [6]. The calculation of the RIS 
of the estradiol binding site and of the hexosaminidase 
activity was performed on the same irradiated samples, 
the hexosaminidase being used as an internal control. 
For hexosaminidase a RIS of 50 000~6000 (mean rt 
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Fig. I. Effect of “‘Co Q radiations at -78°C on intact MCF-7 
samples. Fractional surviving of estrogen receptor binding capacity 
(a), and hexosaminidase nzymatic activity (o), are plotted as a func- 
tion of radiation exposure. Each point is the mean of 2 independent 
experiments realized in triplicate. 
SD; n = IS) was obtained (Fig. 1) in good agreement 
with previous reports [lo]. From Fig. 1 we found that 
the RIS of estradiol binding on intact untreated cells is 
25 OOO+ 3000. About the same value, was obtained 
after either estradiol or tamoxifen cell treatments and 
independently of the cell density (Fig. 2). This 
molecular size does not correspond to the whole hetero- 
oligomer [3] nor to the M, = 67 000 estrogen receptor 
polypeptide [ll], but it fits with the size of the estradiol 
binding domain [12]. To insure that the decrease of bin- 
ding was not due to a variability of the affinity of the 
receptor for its ligand following radiations, the 
dissociation constant at equilibrium (&I) was determin- 
ed at 10 different radiation doses and 6 different ligand 
concentrations. Both the RIS and & were determined 
as not significantly different (Fig. 3). However, another 
possibility, to explain the low RIS analysis could have 
been an artefactual release of masked receptors induced 
by irradiating intact cells. ‘To test this possibility 
another set of radiation experiments has been con- 
ducted on cytosolic extracts. In these conditions, the 
same RIS value is found again for all cell culture condi- 
tions and treatments (data not shown). This is com- 
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Fig. 2. Radiation inactivation analysis of estrogen receptor after dif- 
ferent MCF-7 cell treatments. MCF-7 cells in log phase growth 
(*, b , it ), or at confluency (0, A , 0 ), were submitted to: vehicle (*,o), 
10-s M estradiol (A, a), IO-’ M tamoxifen (I ,o). The slope 
(/I _ ,bac) of the line was used to calculate RIS = p _ 780~ x 1.2836 x 
IO”. 
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Fig. 3. Influence of irradiation on the & of estradiol binding. MCF-7 
cells in log phase growth were irradiated at -78’C. The natural 
logarithm of fractional surviving binding activity [ln (AD/&)] as a 
function of radiation exposure was assessed by measuring specific 
estradiol binding over the concentration range 0.1-10 nM. In a view 
of clarity only 4 concentrations are plotted here (IO nM, e; 2.5 nM,, 
o; 1 nM. A ; 0. I nM. X). The independence of the KD at various radia- 
tion doses shown on the insert was checked by a Student’s f-test. The 
coefficient of correlation for 10 points is r=0.138. This is not signifi- 
cant (at 5%) I= 0.39, evidencing that KU is not influenced by radia- 
tion doses. 
pletely different from the highly homologous androgen 
receptor whose RIS corresponds to the whole receptor 
polypeptide [13]. The reason for such a discrepancy is 
not clear. We thus conclude that the RIS for estradiol 
binding (25 000 c 3000) determined by radiation 
analysis corresponds to the hormone binding domain 
previously described [l%]. RIS usually relates to the 
monomer or the oligomer. However, occasionally, the 
RIS is much smaller than the known subunit size and 
has been attributed to a putative domain [7]. Moreover 
it is shown here that a single radiation hit on the M, 
6? 000 protein structure of the estrogen receptor is not 
fully efficient in disrupting its whole polypeptide chain, 
suggesting that the energy deposited by a hit on the pro- 
tein is not necessarily transferred to the hormone bin- 
ding domain. only direct hits of this domain would 
destroy the estradiol binding capacity. This result in- 
tegrates into a larger mechanism suggesting that under 
radiation: (i) the fragmentation of a polypeptide could 
preferentially occur in loops or B-turns of the chain 
[14]; and (ii) each domain exerting a function in- 
dependently of the others, in a multidomain protein, 
could be inactivated independently by a direct hit [14]. 
Finally the fact that in the whole cell, a same RIS value 
was obtained in absence or in presence of antiestrogenic 
agents indicates that the important biological dif- 
ferences induced by agonist and antagonist ligands do 
not proceed from the intervention of other receptor do- 
mains or proteins. Thus, the loops and/or @-turns of 
the polypeptide chain close to the binding domain are 
not drastically modified by the binding of some ligand 
on the estrogen receptor. 
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